Equities researchers at StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a research report issued to clients and investors on Wednesday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Stock Performance
Sorrento Therapeutics stock opened at $0.00 on Wednesday. Sorrento Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25.
Sorrento Therapeutics Company Profile
Read More
- Five stocks we like better than Sorrento Therapeutics
- What Does Downgrade Mean in Investing?
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- Election Stocks: How Elections Affect the Stock Market
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- What Are the U.K. Market Holidays? How to Invest and Trade
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.